Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-09-22
2000-07-18
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544364, C07D29512, A61K 31496
Patent
active
060908122
ABSTRACT:
A group of new piperazine and piperidine compounds having interesting advantageous pharmacological properties and have the formula (a) ##STR1## wherein A represents a heterocyclic group having 5-7 ring atoms wherein 1-3 heteroatoms selected from the group O, N and S are present,
REFERENCES:
patent: 5436246 (1995-07-01), Bernotas et al.
Van Steen et al., "Structure-Affinity Relationship Studies on 5-HTIA receptor Ligands. 2. Heterobicyclic Phenylpiperazines With N4-Aralkyl Substituents", J. Med. Chem., 37(17):2761-2773 (1994).
den Hartog Jacobus A. J.
Feenstra Roelof Willem
Kruse Cornelis G.
Long Stephen K.
Tulp Martinus T. M.
Duphar International Research B.V.
Gerstl Robert
LandOfFree
Piperazine and piperidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazine and piperidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine and piperidine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2037419